Target intelligence / Profile preview

Endogenous Bornavirus-like nucleoprotein 3, pseudogene (EBLN3P)

Target
EBLN3P
Molecular classification
Other (pseudogene-derived long non-coding RNA, lncRNA)
01

Overview

Endogenous Bornavirus-like nucleoprotein 3, pseudogene (EBLN3P) is a pseudogene-derived long non-coding RNA found in the human genome[1][5]. Unlike protein-coding genes, pseudogenes like EBLN3P do not produce functional proteins but can regulate gene expression through RNA-mediated mechanisms[2]. Recent research indicates that EBLN3P is upregulated in osteosarcoma, where it acts as a competitive endogenous RNA (ceRNA), sponging microRNA miR-224-5p and modulating Rab10 expression, ultimately promoting tumor cell proliferation, migration, and invasion[2]. Although EBLN3P has no direct links as a therapeutic target or drug interactor, its regulatory role in cancer biology makes it a research interest for future diagnostic or prognostic approaches[2][5]. This molecule is best classified as a pseudogene-derived long non-coding RNA involved in cancer-related gene regulation, not as a classical drug target or receptor[2][5].

Other names
LOC100506710EBLN3endogenous Bornavirus-like nucleoprotein 2 pseudogeneEBLN3P
02

Mechanism of action

Not applicable; drugs do not target EBLN3P. Mechanistically, EBLN3P acts as a sponge for microRNAs (e.g., miR-224-5p) affecting gene expression networks related to cancer progression

03

Biological functions

Competing endogenous RNA (ceRNA) activityRegulation of gene expressionPromotion of cell proliferation, migration, and invasion in cancer cells (specifically osteosarcoma cells via interaction with microRNAs and Rab10)
04

Disease associations

Cancer—promotes osteosarcoma progressionOther—potential roles in other cancers by analogy to characterized pseudogene-derived lncRNAs
05

Safety considerations

None documented, as it is not a therapeutic target or part of a drug pathway
06

Biomarkers

None established for clinical use. Expression levels may be investigated as research biomarkers in osteosarcoma

Beyond the preview

Go deeper on Endogenous Bornavirus-like nucleoprotein 3, pseudogene (EBLN3P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endogenous Bornavirus-like nucleoprotein 3, pseudogene (EBLN3P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call